|
| |
| | | 53892 | | 29.11.1996 | | Opella Healthcare Switzerland AG | | 28.04.2006 | | | | | 31.12.2024 | | | | | | 12.02.30. | | 07.02.2025 | | 12.02.30. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Nasacort | Nasenspray | Nasenspray (Triamcinolon Acetonid 0.55 mg/ml) | R01AD11 | PI | | 02 | Nasacort Dosierspray | | (Triamcinolon Acetonid 55 mcg) | | |
|
|
|
